 Healthcare companies worldwide have benefited from subsidies and increased demand as a result of the coronavirus crisis, but they have also faced new costs, including protective gear. Fresenius first-quarter net income was 465 million euros 503.97 million, above analysts average forecast of 421.8 million euros, a Refinitiv poll found. It is, however, too early to say with any certainty what impact COVID-19 will have on the companys full business year, Chief Executive Stephan Sturm said in a statement. 